| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.007 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |